GSK Egypt's profits skyrocket 454% in 2021; dividends proposed

Reuters Images/Amr Abdallah Dalsh

The board has proposed a cash dividend distribution of EGP 0.75 per share for 2021

Staff Writer, Mubasher

May 16, 2022

PHOTO

Cairo - The unaudited consolidated financials of GlaxoSmithKline (GSK Egypt) reported a 454 surge in net profits to EGP 155 million in 2021 from EGP 28 million in 2020.

The company's sales retreated by 9% to EGP 1.81 billion in 2021, compared to EGP 1.99 billion in the previous year, according to a bourse filing on Sunday.

As for the standalone businesses, the company's net profits increased to EGP 166 million last year from EGP 44 million in 2020.

Meanwhile, the board has proposed a cash dividend distribution of EGP 0.75 per share for 2021.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.